Literature DB >> 26523796

The case for periodic OPV routine vaccination campaigns.

Nicolas Houy1.   

Abstract

The possibility of periodic routine vaccination campaigns (PRVCs) is introduced in the context of a search for optimal oral poliovirus vaccine (OPV) administration strategies. Like the usual continuous routine vaccination campaign (CRVC), PRVCs target only newborns. However, they are not necessarily implemented continuously in time. Using a dynamic and compartmental polio transmission model in a stochastic context, it is shown that some PRVCs can achieve much greater efficiency than CRVC in terms of probability of wild poliovirus (WPV) eradication, even though they never outperform CRVC in terms of total number of paralytic infections. Moreover, these PRVCs results can be obtained at a lower price than CRVC. It is also shown that, even though PRVCs do not perform better than pulse vaccination campaigns (PVCs) when only epidemiological outputs are valued, they can do so when a cost-benefit analysis is preferred.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oral poliovirus vaccine; Periodic vaccination; Poliovirus; Pulse vaccination; Routine vaccination

Mesh:

Substances:

Year:  2015        PMID: 26523796     DOI: 10.1016/j.jtbi.2015.09.032

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  3 in total

1.  Optimal vaccination strategies and rational behaviour in seasonal epidemics.

Authors:  Paulo Doutor; Paula Rodrigues; Maria do Céu Soares; Fabio A C C Chalub
Journal:  J Math Biol       Date:  2016-04-05       Impact factor: 2.259

Review 2.  Quantitative Microbial Risk Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric Pathogens.

Authors:  Andrew F Brouwer; Nina B Masters; Joseph N S Eisenberg
Journal:  Curr Environ Health Rep       Date:  2018-06

Review 3.  Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Expert Rev Vaccines       Date:  2020-08-01       Impact factor: 5.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.